Treatment with BRAF/MEK: inhibitors in mutant BRAF V600E papillary craniopharyngioma

Craniopharyngiomas (CPs) are rare brain epithelial tumours arising in the suprasellar region, infiltrating adjacent areas causing visual loss, panhypopituitarism, cognitive deficits and morbid obesity. Papillary CPs (PCPs) harbour in 94% BRAF mutation cases. Two patients with PCP and BRAF V600E muta...

Full description

Bibliographic Details

Published in:	Endocrine Oncology
Main Authors:	Eva Marie Erfurth, Peter Siesjö, Pia C Sundgren, Björn Hammar, Sara Kinhult
Format:	Article
Language:	English
Published:	Bioscientifica 2024-12-01
Subjects:	craniopharyngioma papillary craniopharyngioma braf mutation braf and mek inhibitors
Online Access:	https://eo.bioscientifica.com/view/journals/eo/4/1/EO-24-0024.xml